Macrophage uptake of modified forms of LDL leads to cellular cholesterol accumulation. Upon incubation of LDL with phospholipase D (PLase D), a time-and enzyme dose-dependent production of phosphatidic acid (PA), paralleled by a rapid reduction in LDL phosphatidyl choline content (up to 65% within 15 min of incubation) was noted. 
Introduction
Macrophage cholesterol accumulation, which is an early event in atherogenesis, could not be achieved after cell incubation with native LDL but was demonstrated after macrophage incubation with modified forms of LDL (1) (2) (3) (4) . Unlike native LDL, which is taken up by the cells via the cholesterol-regulated LDL receptor, acetyl LDL and oxidized LDL are taken up by the scavenger receptor(s), leading to cellular cholesterol accumulation (1) (2) (3) (4) . Macrophage cholesterol accumulation could also be obtained with other forms of LDL (not taken up by the scavenger receptor) that were modified in their lipids moieties by various means, including the action of several lipases on the lipoprotein (5) (6) (7) (8) (9) (10) (11) (12) (13) .
Phospholipases exist in almost every type of cell, possess hydrophobic nature, and regulate the acyl composition of the cell membrane phospholipids ( 14) .
The products of phospholipase action on cells ( 14) include second messengers (such as inositol phosphate and diacylglycerol), products ofthe arachidonic acid cascade (such as prostaglandins and leukotriens), and other active metabolites (such as lysophospholipids and phosphatidic acid). Phospholipase action on the surface of LDL phospholipids can "uncover" the core lipids ofthe lipoprotein and thus affect its interaction with cells. Phospholipase (PLase)' A2, which specifically attacks fatty acids at the C-2 position of the diacyl glycerol phospholipids, was shown to modify LDL to a form that was taken up by macrophages at enhanced rate (9) but adhered in a nonspecific way to fibroblasts and was not degraded to any significant extent by these cells (1O). PLase C, which selectively removes the polar phosphorous moiety of the LDL phospholipids, causes the loss of its hydrophilic portion and forces the modified LDL to aggregate and to form particulate PLase C-LDL (11). PLase C-LDL is taken up via the macrophage LDL receptor by phagocytosis and was shown to form foam cells ( 11, 12) . Sphingomyelinase-treated LDL was also shown to be taken up by macrophages at an enhanced rate ( 13) .
PLase D, unlike PLase C, hydrolyzes only the alcohol moiety of the phospholipid (such as the choline residue) and not the phosphorous moiety and thus results in the formation of phosphatidic acid (PA). PLase D plays a role in cell activation process and its presence in plasma has been reported recently (15, 16) .
The present study was undertaken to find out the effect of PLase D on the physicochemical properties of LDL and on in its interaction with cells. The results of this study show that PLase D-LDL is taken up by cells at an enhanced rate and this can be attributed to the physicochemical changes that occur in the modified lipoprotein and to the formation of PA.
Methods
Materials. PLase D (EC 3.1.4.4) ofcabbage origin was purchased from Boehringer Mannheim GmbH (Mannheim, Germany). This PLase D preparation was used because, unlike PLase D from streptomyces chromofuscus, it does not contain proteases. Ficoll-Paque and Sephadex G-100 were purchased from Pharmacia Fine Chemicals (Piscataway, NJ). BioGel A 15m column was purchased from Bio-Rad Laboratories (Richmond, CA). DME, RPMI 1640 culture medium, FCS, penicillin, streptomycin, and L-glutamine were obtained from Gibco Laboratories (Grand Island, NY). Carrier-free Na I was obtained from DuPontNew England Nuclear (Boston, MA). A mAb, BIB6, towards the apolipoprotein B-I00 epitopes that are located at the LDL receptor-binding domain (mapped to amino acid residues 3,214-3,506) was a generous gift from Drs. G. Schonfeld and E. Krul (Washington University, St. Louis, MO).
Cells. J-774A. 1 murine macrophage-like cell line was purchased from American Type Culture Collection (Rockville, MD). J-774A. 1 cells were plated at 2.5 X 105 cells per 16-mm dish in DME supplemented with 10% FCS. The cells were fed every 3 d and were used for experiments within 7 d of plating (5) .
Human monocytes were isolated by density gradient centrifugation from blood derived from fasting normolipidemic subjects (17) . 20 ml ofblood (anticoagulated with 10 U/ml ofheparin) was layered over 15 ml of Ficoll-Paque and centrifuged at 500 g for 30 min at 230C. The mixed mononuclear cell band was removed by aspiration, and the cells were washed twice in RPMI 1640 culture medium containing 100 U/ ml penicillin, 100 Ag/ml streptomycin, and 2 mM glutamine. The cells were plated at 3 x 105 monocytes per 16-mm dish (Primaria; Falcon Labware, Oxnard, CA) in the same medium. Human monocytederived macrophages (HMDM) were used within 7-10 d of plating.
Human skin fibroblasts (HSF) were cultured from punch biopsies of the skin of the anterior thigh from normal volunteers (18) . Subcultures were used between passages 4 and 12. The cells were plated at 5 X I05 cells per 16-mm dishes in DME supplemented with 10% FCS, 100 U / ml penicillin, 100 ,g/ ml streptomycin, and 2 mM glutamine. After 5 d in culture, the medium was changed to DME supplemented with 10% human lipoprotein-deficient serum (d > 1.25 g/ml, prepared by ultrace centrifugation) for 48 h to upregulate cellular LDL receptors.
Lipoproteins. LDL was prepared from human plasma derived from fasted normolipidemic volunteers. LDL was prepared by discontinuous density gradient ultracentrifugation as described previously (19) . The LDL was washed at a density of 1.063 g/ml and dialyzed against 150 mM NaCl, 1 Lipoproteins were analyzed for possible changes in their charge by lipoprotein electrophoresis on agarose (27) . Vitamin E content of the lipoproteins was analyzed with the bathophenantroline-ferric chloride assay (28) . The concentration of total carotenoids was determined in the lipoprotein fractions by HPLC ofthe lipid extracts (29) . LDL fatty acids distribution was analyzed by gas-liquid chromatography as described elsewhere (30 For phospholipid subclasses analysis, the LDL lipids were extracted with chloroform/methanol (2:1, vol/vol) and the lipid extract was analyzed for its content of PA, phosphatidyl choline (PC), and phosphatidyl inositol (PI) by TLC on silica gel plates. The plates were developed with a solution of chloroform/methanol/ammonium hydroxide (60:35:8, vol/vol/vol). Iodine vapors were used to visualize the lipid spots on the TLC plates using the appropriate standards. The appropriate spots of PA, PC, and PI were scraped and analyzed for their phosphorous content (26) . Transphosphatidylation in plasma was studied by plasma incubation with 5 mM CaCl2 and 20% methanol for 2 h at 370C. The production of phosphatidyl methanol was visualized using the appropriate standards. Phospholipid mass was calculated by multiplying the phosphorous content by 25 for PC and PI and by 22 for PA.
For analysis of the physicochemical characteristics of PLase D-LDL and for lipoprotein-cell interaction studies, the modified lipoprotein was separated from excess phospholipases and from lipolyzed products by a second ultracentrifugation at a density of 1.210 g/ml or by passage over a Sephadex G-100 minicolumn ( 10 X 2 cm), which was then eluted with 50 mM saline-EDTA (1 mM) buffer (pH 7.4).
Metabolism oflipoprotein by cells. LDL degradation was measured after incubation of 1251I-labeled LDL ( 180-300 cpm/ng ofprotein) with cells for 5 h at 370C under conditions as described for each specific experiment. The hydrolysis of LDL protein was assayed in the incubation medium by measurement of trichloroacetic acid-soluble, noniodide radioactivity (32) . Cell-free LDL degradation was minimal and was subtracted from total degradation. The cell layer was washed three times with PBS and extracted by a 1-h incubation at room temperature with 0.5 ml of 0.1 N NaOH for measurement of protein by the method of Lowry et al. (23) and for determination of cell-associated I-labeled lipoproteins. The mAb B1B6, which binds to the LDL receptor-binding domains on LDL apo B-100, was used to assess binding of the lipoprotein to the LDL receptor (33) .
High affinity binding of lipoproteins to cells was studied by incubation of '25W-labeled lipoproteins for 4 h at 4°C. After extensive washing (4x) with PBS, cells were extracted by incubation with 0.1 N NaOH for 1 h at room temperature and the bound radiolabeled LDL was counted (34) . LDL cholesterol uptake by cells was estimated by measurement of the stimulation of 3[H]oleate incorporation into cholesteryl ester (35) . The cells were incubated for 18 h with the lipoproteins, followed by medium removal and a further incubation of the cells with the radiolabeled oleate (0.2 mM, 10 4Ci/ml 3[H] oleate in the presence of 0.07 mM fatty acid-free albumin) for 2 h at 37°C. The cells were then washed twice with PBS at 4°C and incubated for 30 min with 1 ml of hexane/ isopropyl alcohol (3:2, vol/vol) in a 16-mm dish at room temperature to extract cellular lipids. After two more washes with these solvents, the pooled lipid extract was dried under nitrogen and resolubilized in chloroform. The labeled CE was isolated by TLC on silica gel plates using hexane/diethyl ether/acetic acid solution (130:40:1.5, vol/vol/vol). Cellular content of unesterified cholesterol and CE was determined after lipid extraction (24) .
Heparin Sepharose affinity chromatography. Subfractionation of LDL and PLase D-LDL by heparin Sepharose was carried out as previously described (33) . Sepharose complexed with heparin (Affi-gel Heparin; Bio-Rad Laboratories) was packed into a small column (10 X 2 cm). The column was saturated with BSA and equilibrated to 0.05 M NaCl, 2 mM phosphate buffer (pH 7.4). 1 mg lipoprotein protein was applied to the column and elution was begun at a flow rate of 30 ml/h. After the unbound fraction was eluted (and the absorbance at 280 nm had decreased to baseline), the retained fraction (bound) was eluted with 0.8 M NaCl. Recovery (39) . '25I-labeled lipoprotein samples (10 mg of protein in 3 ml) were loaded on top of the column (85 X 1.6 cm) and 2-ml fractions were collected using 0.9% NaCl, 0.01% Na2 EDTA, 0.01% NaN3, pH 7.4, as the eluant, at a flow rate of 10 ml/h. The radioactivity was then measured in each fraction. Free lysin amino groups in LDL were estimated with trinitrobenzenesulfonic acid (TNBS). LDL (50 ,ug protein) was mixed with 1 ml of 4% NaHCO3, pH 8.4, and 50 ,d of0.1% TNBS and heated for 1 h at 37°C, after which the absorbance at 340 nm was measured (40).
LDL-free fatty acid content was analyzed colorimetrically, using a NEFA C kit (Wako Pure Chemicals, Osaka, Japan), on the basis of (Table I) . On using 5 U/ml PLase D, LDL phosphatidyl choline content was significantly reduced (by 36%) with no significant changes in the other LDL lipid constituents (Table I ). The relative content of PLase D-LDL polyunsaturated fatty acid linoleate was increased by 14% (Table I) and LDL content of the antioxidants vitamin E and carotenoids were reduced in PLase D-LDL by 20 and 25%, respectively, in comparison with native LDL (Table I) . These latter changes however were not statistically very significant (P < 0.05). TNBS reactivity (which measures the content of free epsilon amino lysine groups on the LDL apo B-100) of PLase D-LDL was similar to that of native LDL (data not shown). On heparin Sepharose minicolumn, 72±5% of the PLase D-LDL protein was recovered in the unbound fraction in comparison with only 6±4% of native LDL that was obtained in this fraction under similar chromatography conditions (n = 3). Analysis of PLase D-LDL on SDS-PAGE revealed no fragmentation of the modified lipoprotein and on nondenatured gradient gel electrophoresis, the size of PLase D-LDL was found to be somewhat smaller than that of native LDL (the PLase D-LDL particle migrated 13.5±0.3 mm from the top of the gel in comparison with a migration of 12.2±0.3 mm for native LDL), and no particles with molecular weight higher than that of native LDL could be found, suggesting that lipoprotein aggregation did not take place in PLase D-LDL. Furthermore, on using 251I-labeled LDL and PLase D-'251I-labeled LDL, analysis of the radioactivity after high speed centrifugation (10,000 g for 10 min) in the supernatant compared with that ofthe whole sample revealed 1.5±0.3 and 1.7±0.5% aggregation for LDL and PLase D-LDL, respectively (n = 3). As the centrifugation procedure may not remove small aggregates (up to -500 nm in diameter) and since small aggregates of modified LDL could still account for a substantial increase in LDL degradation, we have also performed column chromatography analysis on a Bio Gel A 15m column (4% agarose, 200-400 mesh beads) of 1 mg protein/ml '251-labeled LDL or PLase D-251I-labeled LDL (using 5 U /ml of PLase D). Both preparations were eluted as a single peak with no residual radioactivity present at higher or at lower particle size ( 1251I-labeled LDL was eluted at eluant peak volume of 95±5 ml and PLase D-'251I-labeled LDL, at 99±3 ml [n = 3]). No radioactivity could be found in fractions collected before the lipoprotein peak, when concentrations up to 15 U/ml PLase D were used. When higher concentrations of PLase D were used, however, some aggregates appeared. Only when using 25 U/mi PLase D was some residual radioactivity associated with fractions collected at 83±5 ml of the eluant volume (before the main lipoprotein peak), which accounted for 2.8±0.5% of the total lipoprotein radioactivity (n = 3). As in our experiments, the concentration of PLase D was only 5 U/ ml, thus, no aggregates were present in the modified LDL used in the present study. The electrophoretic mobility of PLase D-LDL on cellulose acetate was increased by 28±5% in comparison with native LDL (from 1.3±0.2 [LDL] to 1.7±0.1 cm [PLase D-LDL] from the origin, respectively, n = 3). No lipolysis of PLase D-LDL esterified fatty acids could be found, as the content of LDL-associated free fatty acids in native LDL and in PLase D-LDL were similar (87±16 vs. 101±23 mol of free fatty acids/mol apo B-100, respectively). PLase D-LDL was not oxidized (data not shown) as analyzed by the peroxide and conjugated dienes assays (30) . When PLase D-LDL was oxidized in the presence of copper ions, however, the content oflipoprotein-associated peroxides increased in a dose-dependent fashion (ofthe enzymatic activity) by up to 153% elevation (when 10 U/ml of PLase D was used) in comparison with native LDL (Table II) . Simi- larly, the conjugated dienes content of LDL increased from 185±14 nmol/mg LDL protein in the absence of PLase D to 285±21 and 311±17 nmol/mg LDL protein when 5 and 10 U/ml ofthe enzyme were used, respectively (P < 0.01, n = 3). In vitro oxidation of native LDL by its incubation with 10pM CuS04 for 24 h at 370C in the presence of increasing concentrations of PA resulted in an increment in LDL-associated peroxides from 116±20 (in the absence of PA) to 166±17 and 189±21 nmol/ mg LDL protein in the presence of 50 and 100 pg PA/ml, respectively (P < 0.01, n = 3). Similarly, LDL-associated conjugated dienes increased from 177±23 to 250±23 and 288±17 nmol/mg LDL protein, respectively (P < 0.01, n = 3).
The effect of PLase D on oxidized LDL was also studied. Upon incubation of 5 U/ml PLase D with 1 mg protein/ml of either native LDL or oxidized LDL (produced by LDL incubation with 10,M CuS04 for 24 h at 37°C), the reduction in the lipoprotein PC content as well as the elevation in its PA content were similar for both lipoproteins (data not shown), suggesting that PLase D activity towards LDL was not affected by lipoprotein oxidation.
Macrophage uptake ofPLase D-LDL. Upon using increasing concentrations ofPLase D to modify the LDL, macrophage degradation of the lipoprotein was increased in a dose-dependent fashion by up to 108% when a concentration of 10 U/ml of the enzyme was used (Fig. 2 A) . Similarly, upon increasing the time ofLDL modification with PLase D, the degradation of the modified lipoprotein by macrophages increased with time of incubation by up to 117% in comparison with native LDL (Fig. 2 B) . We next studied the binding ( (Fig. 3 A) . Analysis of macrophage degradation of PLase D-LDL over a concentration range between 25 and 100 pg protein/ml revealed a 81-110% increased macrophage degradation of PLase D-LDL in comparison with native LDL (Fig. 3 B) . Cellular degradation of PLase D-LDL was completely inhibited by 50 pAM of chloroquin, the inhibitor of lysosomal enzymes (data (Table IV) . The unlabeled LDL reduced PLase D-'251-labeled LDL cellular degradation by 89% whereas unlabeled Ac-LDL and fucoidin, which bind to the scavenger receptor, had only minimal effect on PLase D-LDL cellular degradation (Table IV) . Preincubation of PLase D-1251-labeled LDL with mAb B1B6 (directed against epitopes of the LDL receptor-binding domains on the LDL apo B-I00 molecule) inhibited cellular degradation ofthe labeled lipoprotein by 80% (Table IV) . The involvement of the macrophage LDL receptor in the cellular uptake of PLase D-LDL was further assessed in J-774A. 1 macrophages that were preincubated for 24 h at 37°C with 10% lipoprotein-deficient serum (to upregulate the LDL receptor), as well as in cells that were loaded with cholesterol (cellular cholesterol increased from 33±8 to 74±11 ,g/mg cell protein) by preincubation of the cells with 100 sg/ml ofAc-LDL (to downregulate the LDL receptor). In control cells (with no pretreatment), PLase D-251I-labeled LDL (25 ,ug protein/ml) degradation rate was 1,335±131 ng/ mg cell protein per 5 h whereas, in the upregulated cells and in (Fig. 4 A) and cell association (Fig. 4 B) of PLase D-LDL was elevated by -1.8-fold in comparison with native LDL over all time points (Fig. 4) . The cellular processing of PLase D-LDL was studied in a pulse-chase experiment. J-774A. 1 macrophages were incubated with 1251-labeled LDL or with PLase D-125I-labeled LDL (25 ug protein / ml) for 4 h (pulse period) followed by cell wash and a further incubation ofthe cells in fresh medium for 2 h (chase period). Fig. 5 demonstrated that the rate of the reduction in cell-associated PLase D-LDL along the first hour of the chase period was 3.5-fold higher than that of native LDL (0.60±0.07 vs. 0.17±0.03 pg LDL protein/mg cell protein per 1 h). We further assessed the processing of PLase D-LDL by the macrophages using lipoproteins that were labeled in the cholesterol of their CE moiety ( [ 4C] CE). The kinetics of the hydrolysis ofthe lipoprotein CE in cells where acyl CoA cholesterol acyl transferase (ACAT) was inhibited (with 50 pM of progesteron) was studied. Under these conditions, lysosomal hydrolysis of the lipoprotein CE occurred but reesterification of the released unesterified cholesterol by ACAT was blocked. This experiment allows for quantitation of the cellular processing ofthe lipoprotein CE. when a concentration of 100 jig PA/ml was used (Fig. 6) (Fig. 7) . Upon incubation ofJ-774A. 1 macrophages with LDL (1 mg protein/ml) in the presence of 5 mM CaCl2 at 370C for 24 h, a 179% elevation in LDL PA content and a 27% reduction in LDL PC content were noted in comparison with LDL that was incubated without cells (Fig. 7) .
Upon incubation of fresh plasma at 370C for up to 1 h in the presence of 5 mM CaC12, a time-dependent formation of PA was noted and it was paralleled by up to a 20% reduction in plasma PC content (Table VI) . Similarly, a CaCl2 dose study revealed that after 1 h ofplasma incubation at 370C, a dose-dependent effect of calcium ions on the elevation in plasma PA concentration was noted (Table VII) . This was accompanied by a substantial reduction in plasma PC concentration (Table  VII) . Furthermore, plasma incubation for only 10 min in the presence of 10 mM CaCl2 resulted in the reduction of plasma PI from 355±27 to 253±17 Mg/ml (26%, n = 3) whereas plasma PC concentration was reduced at the same time from 1,217±27 to only 1, 111±47 ,g/ml (9%, n = 3). Upon incubation of plasma for 1 h at 370C in the presence of 5 mM CaCl2 and 5 mM EDTA, the formation of plasma PA was blocked. Similar results were obtained with the thiol blocking agent, p-hydroxymercuriphenylsulfonic acid (2 mM) or with 10 AM of 1,10 phenanthroline, the transition metal ions chelator (data not shown). Incubation of native LDL in the presence of 5 mM CaCl2 for up to 1 h at 370C, however, did not affect its PC and PA content (data not shown), suggesting that PLase D activity is not associated with LDL. Upon incubation of 1 mg LDL protein/ml with 1o0% (vol/vol) lipoprotein-deficient plasma (LPDP) in the presence of 5 mM CaCi2 for 1 h at 370C, however, the LDL PC content was reduced from 310±21 to 274±17 Mg/ml whereas PA concentration increased from 63±7 to 105±9 ,g/ml (n = 3, P < 0.01), suggesting again the presence of PLase D activity in LPDP. To confirm our finding of PLase D activity in plasma, transphosphatidylation (which is a reaction unique to PLase D) was assessed in plasma. Upon incubation ofplasma in the presence of 5 mM CaCl2 and 20% methanol for 2 h at 370C, the formation ofphosphatidyl methanol was demonstrated by TLC analysis (using a standard of phosphatidyl methanol that was prepared by a 2-h incubation of phosphatidyl ethanolamine with purified PLase D in the presence of 20% methanol at 370C). This transphosphatidylation reaction indeed supports our finding of PLase D activity in plasma.
Further characterization of the plasma PLase D enzymatic activity was carried out by analysis of its pH sensitivity and heat stability. Plasma incubation with 10 mM CaCl2 for 1 h at 370C at pH 7.4 resulted in the elevation of PA concentration from 117± 18 to 244±11 ggg/ml (n = 3). Upon raising the pH to 8.0 or reducing the pH to 7.0 (by plasma dialysis against 25 mM phosphate buffer, 150 mM NaCl with the appropriate pH values), the plasma concentrations of PA were 200±17 and 255±13 jig/ml, respectively (n = 3), and thus pH 7.0 was optimal for plasma PLase D activation. Plasma PLase D activity was heat labile and at pH 7.4 under the above conditions PA production was reduced from 250±19 to 193±15 ,g/ml and to 130±19 ug/ml in plasma samples that were preheated for 5 min to 55 or 100°C, respectively. (42, 43) . The LDL antioxidants vitamin E and fl-carotene were shown to protect the lipoprotein from lipid peroxidation (42) whereas low lipoprotein content of these antioxidants (as in PLase D-LDL) can contribute to its increased propensity for oxidation (42, 43) . In addition, the LDL polyunsaturated fatty acids linoleic acid and arachidonic acid were shown to enhance LDL oxidizability (42) . In PLase D-LDL, both the increased content of linoleic acid and the location of this polyunsaturated fatty acid in the core CE moiety of LDL probably have contributed to its increased oxidizability (43) . The reduced antioxidant content in PLase D-LDL in comparison with native LDL (which could have resulted from conformational changes in PLase D-LDL) and the increased percentage oflinoleic acid (paralleled by some reduction in palmitic, stearic, and oleic acids that could have resulted from some nonspecific fatty acid lipolysis) could possibly have contributed to the increased susceptibility of PLase D-LDL to undergo lipid peroxidation (42, 43) .
The somewhat smaller size of PLase D-LDL in comparison to native LDL may be also responsible for its increased propensity for oxidation, as it was recently shown that the smaller and denser particles of LDL are more prone to oxidation than the larger LDL particles (44) .
The formation of PA on the surface of the modified lipoprotein could have also contributed to this effect. In the present study PA was shown to possess the ability to increase the propensity of LDL to oxidation and, thus, PA may be responsible for the enhanced susceptibility of PLase D-LDL to oxidation. In neutrophils a correlation was shown between the generation of PA and the production of superoxides (45) . PA, which is rapidly produced by a variety of stimulated cells, elicited NADPH-dependent superoxide anion production in neutrophils by a direct interaction with NADPH oxidase (45) . Al Lipid modifications of LDL were previously reported (5-13). It was shown that a reduction in the lipoprotein core triglycerides (7) or CE (46) content by LDL incubation with lipoprotein lipase or cholesterol esterase resulted in an enhanced or reduced cellular uptake of the modified LDLs, respectively. Modifications of the LDL surface lipids (unesterified cholesterol and phospholipids) were previously studied. Upon oxidation of the LDL unesterified cholesterol with cholesterol oxidase, cholestenone was formed on the surface ofthe lipoprotein and the cholesterol oxidase-LDL was taken up by macrophages at an increased rate (5) .
Besides unesterified cholesterol, phospholipids also contribute to the surface coat of the lipoprotein. Phospholipase treatment of LDL was shown to result in the formation of a modified form of LDL with altered physicochemical properties depending on the type ofphospholipase used (9) (10) (11) (12) (13) . Both PLase C and PLase D act on the phosphoryl group of phospholipids, but PLase D, unlike PLase C, does not remove the phosphorous moiety of the phospholipid. PLase D removes only the alcohol portion ofthe phospholipid, resulting in the formation of PA on the surface of the lipoprotein ( 14) .
PA was shown in the present study to increase cellular uptake of LDL in a dose-dependent fashion and this may have resulted from the action of PA as a "second messenger" as was demonstrated in other cells (47, 48 These changes, as pointed out, could be related to the decrease in heparin binding, the increased immunoreactivity against mAb B 1 B6, the elevated levels oflinoleic acid, and the reduced content of the lipoprotein antioxidants. Differential cellular processing of lipoproteins may have contributed to the ability of PLase D-LDL to stimulate intracellular cholesterol esterification more than native LDL as was previously shown for B-VLDL (49) . This is suggested since the kinetic of macrophage uptake and degradation of PLase D-LDL was more rapid than that of native LDL. Furthermore, in the pulse-chase experiment, the rapid reduction in the cell association of PLase D-LDL in comparison with native LDL also suggests a different intracellular processing for the native and the modified lipoproteins. As both native LDL and PLase D-LDL are internalized via the LDL receptor, and since there were no aggregates in PLase D-LDL, the accelerated cellular catabolism of the modified LDL is probably the result of increased susceptibility to lysosomal enzymes. A physiological relevance of PLase D-LDL is suggested since PLase D activity was demonstrated in the present study both in macrophages and plasma. Under the experimental conditions of macrophage incubation with relatively high calcium ions concentration, no cell death occurred and thus the PLase D was probably secreted from the cells. This calcium ion-mediated PLase D release from macrophages may not occur normally in vivo. However, under conditions such as increased local concentration of calcium ions (activation by second messengers) it may be operated. No PLase D activity could be found in association with native LDL but plasma was shown to possess significant PLase D activity, as was recently shown for another type of PLase D (15, 16) . Considerable similarities are shared by the plasma glycosylphosphatidylinositol and PLase D activities of phagocytes ( 15, 16, 47, 48) . PLase D activity possesses broad substrate specificity and is able to hydrolyze choline-, ethanolamine-, and inositol-containing phosphoglycerides. PLase D from human neutrophils and monocytes, such as plasma PLase D but not endothelial cells PLase D, was shown to be calcium dependent ( 15, 16, 48) . In the present study, plasma PLase D activity was found to be calcium dependent and act on both PI and PC. It is ofinterest that plasma PLase D activity demonstrated much higher affinity towards plasma PI in comparison with plasma PC. After 1 h of plasma incubation in the presence of 10 mM CaCl2, the PI was reduced by 32% in comparison with only 23% reduction in plasma PC concentration. This difference was much greater when comparing the reduction in plasma PI and PC after only 10 min of incubation (26 and 9%, respectively). Another plasma PLase D activity was recently shown to be specific for phosphatidylinositol glycan but not towards PC or PI (50) . This plasma PLase D activity, however, was more heat stable and was stimulated at lower pH than the plasma PLase D activity shown in the present study. Because the transphosphatidylation reaction is unique to PLase D, the formation of phosphatidylalcohol is a useful indicator ofPLase D activity. In the present study we have successfully demonstrated the formation ofphosphatidyl methanol in plasma after 1 h of plasma incubation in the presence of 5 mM CaCl2 and methanol. Finally, the PLase D activity of LPDP on LDL suggests again the presence of PLase D activity in plasma but not in association with plasma lipoproteins. The finding of PLase D activity in plasma is of major importance since this activity may play an important role in vivo in phospholipid metabolism.
The interactions of modified lipoproteins with cells involve different pathways, including lipoprotein uptake via the LDL receptor or the scavenger receptor(s) and also a nonreceptor internalization of the LDL cholesterol. The accumulation of cholesterol in arterial wall macrophages and the formation of foam cells during atherogenesis involve more than one mechanism ( 1-12, 5 1 ). LDL modifications that affect foam cell formation are associated with changes in the LDL lipids moieties as well as with the oxidation of the lipoprotein fatty acids and cholesterol constituents ( 1-13). PLase D modification of LDL can contribute to macrophage cholesterol accumulation by both of these mechanisms since it produces modified LDL (which is taken up by the LDL receptor at an enhanced rate) and since this modified LDL is easily oxidized to a form that is taken up at enhanced rate via the macrophage scavenger receptor, leading to foam cell formation.
